title: Clinician perceptions, expectations, and management of negative symptoms in schizophrenia.
abstract: Negative symptoms in schizophrenia negatively affect patients' social and occupational functioning, as well their long-term recovery. Patients may not overtly complain about negative symptoms, which can make them even more challenging to recognize. Clinicians should ask specific questions regarding negative symptoms, determine if the symptoms are primary or secondary, and then address them accordingly. This activity discusses recognizing negative symptoms in patients with schizophrenia and then addressing those symptoms in spite of a paucity of treatment options.
authors: Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine, Los Angeles.
authors: Stephen R
authors: SR
authors: Marder
mesh_terms: D000342:Affective Symptoms / Q000175:diagnosis* / Q000523:psychology; D059445:Anhedonia; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D057565:Apathy; D001037:Aphasia / Q000175:diagnosis* / Q000523:psychology; D001291:Attitude of Health Personnel; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D004359:Drug Therapy, Combination; D006801:Humans; D007600:Judgment; D012559:Schizophrenia / Q000175:diagnosis*; D012565:Schizophrenic Psychology; D014836:Volition
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents